Detalles de la búsqueda
1.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385243
2.
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life.
Acta Haematol
; 144(3): 322-326, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892194
3.
The Metabolomic Profile of Lymphoma Subtypes: A Pilot Study.
Molecules
; 24(13)2019 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248049
4.
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Br J Haematol
; 183(5): 755-765, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407629
5.
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Lancet Oncol
; 18(8): 1076-1088, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28668386
6.
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.
Blood
; 126(8): 950-6, 2015 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089397
7.
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.
Am J Hematol
; 90(1): 56-61, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25327841
8.
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial.
Blood
; 129(16): 2328-2330, 2017 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264798
9.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181782
10.
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial.
Cancers (Basel)
; 14(1)2021 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008361
11.
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial.
Lancet Haematol
; 8(2): e110-e121, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33513372
12.
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Lancet
; 374(9700): 1512-20, 2009 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-19767089
13.
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study.
Haematologica
; 94(9): 1250-8, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19586937
14.
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
Lancet Oncol
; 9(4): 352-8, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18342572
15.
Activation of the aryl hydrocarbon receptor and risk of lymphoma subtypes.
Int J Mol Epidemiol Genet
; 8(4): 40-44, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29034060
16.
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL).
Thromb Haemost
; 2017 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28447710
17.
CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL).
Front Oncol
; 11: 730194, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804924
18.
Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study.
Leuk Lymphoma
; 57(8): 1823-30, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26666433
19.
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
Cancer Med
; 5(10): 2740-2755, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27665744
20.
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.
Haematologica
; 90(6): 793-801, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15951292